1. Academic Validation
  2. Pharmacokinetic and bioavailability study of angeloylgomisin H in rat plasma by UPLC-MS/MS

Pharmacokinetic and bioavailability study of angeloylgomisin H in rat plasma by UPLC-MS/MS

  • Int J Clin Exp Med. 2015 Oct 15;8(10):17968-76.
Shanjiang Chen 1 Zhuyin Jia 1 Ledan Dong 2 Peiwu Geng 3 Zezheng Liu 4 Suping Yang 4 Congcong Wen 4 Fuli Liu 2
Affiliations

Affiliations

  • 1 Department of Cardiology, Wenzhou Central Hospital Wenzhou 325000, Zhejiang, China.
  • 2 The First Affiliated Hospital of Wenzhou Medical University Wenzhou 325000, Zhejiang, China.
  • 3 The Laboratory of Clinical Pharmacy, The People's Hospital of Lishui Lishui 323000, Zhejiang, China.
  • 4 Laboratory Animal Centre, Wenzhou Medical University Wenzhou 325035, Zhejiang, China.
PMID: 26770391
Abstract

Angeloylgomisin H, as a major lignin in the fruits, was reported to have the potential to improve insulin-stimulated glucose uptake by activating PPAR-γ. In this work, a sensitive and selective UPLC-MS/MS method for determination of angeloylgomisin H in rat plasma is developed. After addition of rutin as an internal standard (IS), protein precipitation by acetonitrile was used to prepare samples. Chromatographic separation was achieved on a UPLC BEH C18 column (2.1 mm × 100 mm, 1.7 μm) with 0.1% formic acid and acetonitrile as the mobile phase with gradient elution. An electrospray ionization source was applied and operated in positive ion mode; multiple reactions monitoring (MRM) mode was used for quantification using target fragment ions m/z 523.2-315.1 for angeloylgomisin H, and m/z 611.1-303.1 for IS. Calibration plots were linear throughout the range 5-2000 ng/mL for angeloylgomisin H in rat plasma. Mean recoveries of angeloylgomisin H in rat plasma ranged from 86.2% to 92.5%. RSD of intra-day and inter-day precision were both < 11%. The accuracy of the method was between 93.0% and 104.1%. The method was successfully applied to pharmacokinetic study of angeloylgomisin H after either oral or intravenous administration. The absolute bioavailability of angeloylgomisin H was reported as high as 4.9%.

Keywords

Angeloylgomisin H; UPLC-MS/MS; pharmacokinetics; rat plasma.

Figures
Products